Table 1 General demographic and clinics characteristics
From: Office and 24-hour heart rate and target organ damage in hypertensive patients
Variables | Total (360) | |
|---|---|---|
Age | 56 ± 11 | |
Gender (male %) | 231 (64.2%) | |
Smoking n (%) | 89 (24.7%) | |
Diabetes Mellitus n (%) | 74 (21.0%) | |
Cardiovascular disease n (%) | 18 (5.0%) | |
BMI | 28.1 ± 3.9 | |
Waist circumference (cm) | 97.6 ± 11.2 | |
Antihypertensive drugs n (%) | 161 (44.7%) | |
Diabetics patients on drug therapy n (%) | 51 (68.9%) | |
Office BP (mmHg) | SBP | 138 ± 16 |
DBP | 87 ± 10 | |
HR (bpm) | 74 ± 12 | |
ABPM 24 h (mmHg) | SBP | 123 ± 11 |
DBP | 76 ± 8 | |
HR (bpm) | 72 ± 9 | |
HRV (SDHR) | 10.7 ± 3.3 | |
Awake ABPM (mmHg) | SBP | 127 ± 11 |
DBP | 79 ± 9 | |
HR (bpm) | 76 ± 10 | |
HRV (SDHR) | 9.6 ± 3.3 | |
Sleep ABPM (mmHg) | SBP | 112 ± 14 |
DBP | 66 ± 9 | |
HR (bpm) | 62 ± 8 | |
HRV (SDHR) | 6.8 ± 3.4 | |
Systolic night/day ratio | 0.89 ± 0.08 | |
Diastolic night/day ratio | 0.84 ± 0.10 | |
Night/day HR | 0.82 ± 0.07 | |
Night/day HRV | 0.76 ± 0.38 | |
Fasting glucose (mg/dl) | 99 ± 30 | |
Creatinine (mg/dl) | 0.92 ± 0.20 | |
Total Cholesterol (mg/dl) | 209 ± 37 | |
Triglycerides (mg/dl) | 126 ± 78 | |
Atherogenic index (Total Cholesterol/HDL-Cholesterol) | 4.11 ± 1.13 | |
Renal | Albumin/Creatinine (mg/gr) | 18 ± 79 |
eGFR (ml/min/1.73 m2) | 86 ± 15 | |
Heart | Cornell VDP (mmxms) | 1482 ± 780 |
LVMI (g/m2) | 108 ± 33 | |
Vascular | IMT mean (mm) | 0.74 ± 0.12 |
left ABI | 1.08 ± 0.16 | |
right ABI | 1.09 ± 0.15 | |
Renal TOD, n (%) | 58 (18.0%) | |
Heart TOD, n (%) | 65 (18.3%) | |
Vascular TOD, n (%) | 82 (23.2%) | |
Some TOD, n (%) | 162 (45.0%) | |